Annual Total Long Term Liabilities
$0.00
-$47.00 K-100.00%
31 March 2024
Summary:
Immunovant annual total long term liabilities is currently $0.00, with the most recent change of -$47.00 thousand (-100.00%) on 31 March 2024. During the last 3 years, it has fallen by -$2.24 million (-100.00%). IMVT annual total long term liabilities is now -100.00% below its all-time high of $2.24 million, reached on 31 March 2021.IMVT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 September 2024
Summary:
Immunovant quarterly total long term liabilities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.IMVT quarterly long term liabilities is now -100.00% below its all-time high of $4.03 million, reached on 30 June 2019.IMVT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | 0.0% | -100.0% |
IMVT Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -100.0% | ||
| 5 y | 5 years | -100.0% | -100.0% | ||
| alltime | all time | -100.0% | -100.0% |
Immunovant Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | $0.00(-100.0%) | $0.00(0.0%) |
| Dec 2023 | - | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | $47.00 K(-96.1%) | $47.00 K(-84.6%) |
| Dec 2022 | - | $306.00 K(-50.2%) |
| Sept 2022 | - | $614.00 K(-33.2%) |
| June 2022 | - | $919.00 K(-24.6%) |
| Mar 2022 | $1.22 M | $1.22 M(-27.4%) |
| Dec 2021 | - | $1.68 M(-13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $1.95 M(-1.0%) |
| June 2021 | - | $1.97 M(-11.9%) |
| Mar 2021 | $2.24 M(>+9900.0%) | $2.24 M(-6.4%) |
| Dec 2020 | - | $2.39 M(-10.7%) |
| Sept 2020 | - | $2.68 M(-9.9%) |
| June 2020 | - | $2.97 M(>+9900.0%) |
| Mar 2020 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | - | $0.00(-100.0%) |
| Sept 2019 | - | $4.03 M(0.0%) |
| June 2019 | - | $4.03 M(>+9900.0%) |
| Mar 2019 | - | $0.00 |
| Dec 2018 | $0.00 | - |
FAQ
- What is Immunovant annual total long term liabilities?
- What is the all time high annual total long term liabilities for Immunovant?
- What is Immunovant annual total long term liabilities year-on-year change?
- What is Immunovant quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Immunovant?
- What is Immunovant quarterly long term liabilities year-on-year change?
What is Immunovant annual total long term liabilities?
The current annual total long term liabilities of IMVT is $0.00
What is the all time high annual total long term liabilities for Immunovant?
Immunovant all-time high annual total long term liabilities is $2.24 M
What is Immunovant annual total long term liabilities year-on-year change?
Over the past year, IMVT annual total long term liabilities has changed by -$47.00 K (-100.00%)
What is Immunovant quarterly total long term liabilities?
The current quarterly long term liabilities of IMVT is $0.00
What is the all time high quarterly long term liabilities for Immunovant?
Immunovant all-time high quarterly total long term liabilities is $4.03 M
What is Immunovant quarterly long term liabilities year-on-year change?
Over the past year, IMVT quarterly total long term liabilities has changed by $0.00 (0.00%)